Recent studies conducted in the United States and in Europe have effectively demonstrated the potential of a Parasortix-based blood test in outperforming current tests used to diagnose ovarian cancer. ANGLE, a world-leading liquid biopsy company, has currently invented a cell separation technology ... Read More »
New Test Outperforms CA-125 in Ovarian Cancer Detection
SOURCE: FindaTopDoc.com